FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146253223> ?p ?o ?g. }

• W2146253223 endingPage "285" @default.
• W2146253223 startingPage "278" @default.
• W2146253223 abstract "Background. Inadequate phosphorus control is associated with increased morbidity and mortality in patients with CKD stage 5. Although phosphate binders are often used in patients on peritoneal dialysis (PD), no large randomized controlled studies evaluating their use solely in this population have previously been reported. Methods. In this multicentre, open-label study, adult patients on PD with serum phosphorus >5.5 mg/dl were randomized (2:1) to 12 weeks of treatment with sevelamer hydrochloride or calcium acetate. Doses were titrated to achieve serum phosphorus of 3.0–5.5 mg/dl. Changes in serum phosphorus, calcium, intact parathyroid hormone (iPTH), lipids and plasma biomarkers were assessed. Results. A total of 253 patients were screened, 143 of whom were randomized (sevelamer hydrochloride, n = 97; calcium acetate, n = 46). Treatment groups were well balanced with regard to baseline demographics. Serum phosphorus levels were significantly reduced after 12 weeks with both sevelamer hydrochloride and calcium acetate ( P < 0.001). Serum PTH was also reduced in both groups while serum calcium increased in the calcium acetate group ( P = 0.001) but not in the sevelamer hydrochloride group. Sevelamer hydrochloride was also associated with decreases in total cholesterol, low-density lipoprotein cholesterol and uric acid and an increase in bone-specific alkaline phosphatase (all P < 0.001 versus baseline). Both treatments were well tolerated and safety profiles were consistent with previous reports in haemodialysis patients. Hypercalcaemia was experienced by more calcium acetate-treated patients (18 versus 2%; P = 0.001). Conclusions. In summary, sevelamer hydrochloride provides a reduction in serum phosphorus compared to that obtained with calcium-based binders in PD patients. The effects of sevelamer hydrochloride appear similar in both PD and haemodialysis populations." @default.
• W2146253223 created "2016-06-24" @default.
• W2146253223 creator A5001479828 @default.
• W2146253223 creator A5021873918 @default.
• W2146253223 creator A5026430959 @default.
• W2146253223 creator A5028960807 @default.
• W2146253223 creator A5039974073 @default.
• W2146253223 creator A5040259881 @default.
• W2146253223 creator A5063245254 @default.
• W2146253223 creator A5083782401 @default.
• W2146253223 creator A5089356814 @default.
• W2146253223 creator A5089462896 @default.
• W2146253223 date "2008-08-06" @default.
• W2146253223 modified "2023-10-17" @default.
• W2146253223 title "Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis" @default.
• W2146253223 cites W1964699832 @default.
• W2146253223 cites W1979587730 @default.
• W2146253223 cites W1989716397 @default.
• W2146253223 cites W1993536565 @default.
• W2146253223 cites W1994604536 @default.
• W2146253223 cites W2005489905 @default.
• W2146253223 cites W2022897447 @default.
• W2146253223 cites W2026531757 @default.
• W2146253223 cites W2041250309 @default.
• W2146253223 cites W2045847718 @default.
• W2146253223 cites W2046680053 @default.
• W2146253223 cites W2063734074 @default.
• W2146253223 cites W2064636061 @default.
• W2146253223 cites W2077053969 @default.
• W2146253223 cites W2104257543 @default.
• W2146253223 cites W2105288874 @default.
• W2146253223 cites W2107207648 @default.
• W2146253223 cites W2112521396 @default.
• W2146253223 cites W2120166750 @default.
• W2146253223 cites W2124245235 @default.
• W2146253223 cites W2124252987 @default.
• W2146253223 cites W2153865539 @default.
• W2146253223 cites W2159293127 @default.
• W2146253223 cites W2164919062 @default.
• W2146253223 cites W2181645812 @default.
• W2146253223 cites W4230207520 @default.
• W2146253223 cites W4235484770 @default.
• W2146253223 cites W4238015229 @default.
• W2146253223 doi "https://doi.org/10.1093/ndt/gfn488" @default.
• W2146253223 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18820280" @default.
• W2146253223 hasPublicationYear "2008" @default.
• W2146253223 type Work @default.
• W2146253223 sameAs 2146253223 @default.
• W2146253223 citedByCount "68" @default.
• W2146253223 countsByYear W21462532232012 @default.
• W2146253223 countsByYear W21462532232013 @default.
• W2146253223 countsByYear W21462532232014 @default.
• W2146253223 countsByYear W21462532232015 @default.
• W2146253223 countsByYear W21462532232016 @default.
• W2146253223 countsByYear W21462532232017 @default.
• W2146253223 countsByYear W21462532232018 @default.
• W2146253223 countsByYear W21462532232019 @default.
• W2146253223 countsByYear W21462532232020 @default.
• W2146253223 countsByYear W21462532232021 @default.
• W2146253223 countsByYear W21462532232022 @default.
• W2146253223 countsByYear W21462532232023 @default.
• W2146253223 crossrefType "journal-article" @default.
• W2146253223 hasAuthorship W2146253223A5001479828 @default.
• W2146253223 hasAuthorship W2146253223A5021873918 @default.
• W2146253223 hasAuthorship W2146253223A5026430959 @default.
• W2146253223 hasAuthorship W2146253223A5028960807 @default.
• W2146253223 hasAuthorship W2146253223A5039974073 @default.
• W2146253223 hasAuthorship W2146253223A5040259881 @default.
• W2146253223 hasAuthorship W2146253223A5063245254 @default.
• W2146253223 hasAuthorship W2146253223A5083782401 @default.
• W2146253223 hasAuthorship W2146253223A5089356814 @default.
• W2146253223 hasAuthorship W2146253223A5089462896 @default.
• W2146253223 hasBestOaLocation W21462532231 @default.
• W2146253223 hasConcept C126322002 @default.
• W2146253223 hasConcept C126894567 @default.
• W2146253223 hasConcept C134018914 @default.
• W2146253223 hasConcept C2776036575 @default.
• W2146253223 hasConcept C2777425297 @default.
• W2146253223 hasConcept C2779056158 @default.
• W2146253223 hasConcept C2779148903 @default.
• W2146253223 hasConcept C2779674975 @default.
• W2146253223 hasConcept C2779978075 @default.
• W2146253223 hasConcept C2781208988 @default.
• W2146253223 hasConcept C2908647359 @default.
• W2146253223 hasConcept C519063684 @default.
• W2146253223 hasConcept C71924100 @default.
• W2146253223 hasConcept C90924648 @default.
• W2146253223 hasConcept C99454951 @default.
• W2146253223 hasConceptScore W2146253223C126322002 @default.
• W2146253223 hasConceptScore W2146253223C126894567 @default.
• W2146253223 hasConceptScore W2146253223C134018914 @default.
• W2146253223 hasConceptScore W2146253223C2776036575 @default.
• W2146253223 hasConceptScore W2146253223C2777425297 @default.
• W2146253223 hasConceptScore W2146253223C2779056158 @default.
• W2146253223 hasConceptScore W2146253223C2779148903 @default.
• W2146253223 hasConceptScore W2146253223C2779674975 @default.
• W2146253223 hasConceptScore W2146253223C2779978075 @default.
• W2146253223 hasConceptScore W2146253223C2781208988 @default.

• next